Education
About Us
Working with TipRanks
Follow Us
Vigil Neuroscience, Inc. (VIGL)
:VIGL
VIGL Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vigil Neuroscience Inc News
VIGL FAQ
What was Vigil Neuroscience, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Vigil Neuroscience, Inc.’s market cap?
Currently, no data Available
When is Vigil Neuroscience, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vigil Neuroscience, Inc.’s earnings last quarter?
Currently, no data Available
Is Vigil Neuroscience, Inc. overvalued?
According to Wall Street analysts Vigil Neuroscience, Inc.’s price is currently Undervalued.
Does Vigil Neuroscience, Inc. pay dividends?
Vigil Neuroscience, Inc. does not currently pay dividends.
What is Vigil Neuroscience, Inc.’s EPS estimate?
Vigil Neuroscience, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vigil Neuroscience, Inc. have?
Currently, no data Available
What happened to Vigil Neuroscience, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vigil Neuroscience, Inc.?
Currently, no hedge funds are holding shares in VIGL
Company Description
Vigil Neuroscience, Inc.
Vigil Neuroscience Inc (VIGL) is a biotechnology company focused on the development of novel therapeutics for neurodegenerative diseases. Operating within the healthcare and life sciences sectors, the company is dedicated to harnessing the power of microglia, the brain's resident immune cells, to develop innovative treatments aimed at improving the lives of patients suffering from debilitating neurological conditions. Vigil Neuroscience's core products are in various stages of clinical development, targeting diseases with high unmet medical needs.
Vigil Neuroscience Inc (VIGL) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Achieve Life Sciences
―
Exicure
―
I-MAB
―
Unicycive Therapeutics
―
Caribou Biosciences
―
Ownership Overview
―
Insiders
2.84%
Mutual Funds
― Other Institutional Investors
94.64% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---